Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Immatics US, Inc.
National Institutes of Health Clinical Center (CC)
Biocon Limited
Pfizer
Maastricht University Medical Center
Pfizer
Almirall, S.A.
Immorna Biotherapeutics, Inc.
The Christie NHS Foundation Trust
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
Centre Oscar Lambret
Mayo Clinic
Psyence Australia Pty Ltd
University of Pittsburgh
ViroMissile, Inc.
Pfizer
Children's Oncology Group
Replimune Inc.
Replimune Inc.
Bristol-Myers Squibb
AI Labs Group S.L
Pfizer
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Werewolf Therapeutics, Inc.
ModernaTX, Inc.
Adaptimmune
Teva Branded Pharmaceutical Products R&D, Inc.
Conjupro Biotherapeutics, Inc.
M.D. Anderson Cancer Center
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
AbbVie
AgonOx, Inc.
Elephas
UNC Lineberger Comprehensive Cancer Center
Novartis
CytomX Therapeutics
Elephas
OncoNano Medicine, Inc.
Ohio State University Comprehensive Cancer Center
Inhibrx Biosciences, Inc